Crossref
Comparison of the efficacy of aflibercept, bevacizumab, and ranibizumab after bevacizumab loading doses in diabetic macular edema
Journal of Retina-Vitreous · 2026 · 35 (2) · 138
DOI: 10.37845/ret.vit.2026.35.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Retina-Vitreous, 2026. Verfasst von Hasan Burhanettin Kaptı.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kaptı, H. B. (2026). Comparison of the efficacy of aflibercept, bevacizumab, and ranibizumab after bevacizumab loading doses in diabetic macular edema. Journal of Retina-Vitreous, 35(2), 138. https://doi.org/10.37845/ret.vit.2026.35.18
Vancouver
Kaptı HB. Comparison of the efficacy of aflibercept, bevacizumab, and ranibizumab after bevacizumab loading doses in diabetic macular edema. Journal of Retina-Vitreous. 2026;35(2):138. doi:10.37845/ret.vit.2026.35.18
BibTeX
@article{Kapt2026,
author = {Kaptı, Hasan Burhanettin},
title = {Comparison of the efficacy of aflibercept, bevacizumab, and ranibizumab after bevacizumab loading doses in diabetic macular edema},
journal = {Journal of Retina-Vitreous},
year = {2026},
volume = {35},
number = {2},
pages = {138},
doi = {10.37845/ret.vit.2026.35.18}
}
EUVIMED